美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
61825-302-60	61825-302	HUMAN PRESCRIPTION DRUG	ORPHENGESIC FORTE	Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20200608	N/A	ANDA	ANDA075141	Galt Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770 mg/1; 60 mg/1; 50 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (61825-302-60)
61825-305-60	61825-305	HUMAN PRESCRIPTION DRUG	Norgesic	Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20220516	N/A	ANDA	ANDA075141	Galt Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	385 mg/1; 30 mg/1; 25 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (61825-305-60)
50991-999-06	50991-999	HUMAN PRESCRIPTION DRUG	Norgesic Forte	Orphenadrine Citrate, Aspirin and Caffeine	TABLET, MULTILAYER	ORAL	20220328	N/A	ANDA	ANDA075141	Poly Pharmaceuticals, Inc.	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770 mg/1; 60 mg/1; 50 mg/1	6 TABLET, MULTILAYER in 1 CARTON (50991-999-06)
50991-999-60	50991-999	HUMAN PRESCRIPTION DRUG	Norgesic Forte	Orphenadrine Citrate, Aspirin and Caffeine	TABLET, MULTILAYER	ORAL	20190401	N/A	ANDA	ANDA075141	Poly Pharmaceuticals, Inc.	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770 mg/1; 60 mg/1; 50 mg/1	60 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)
71993-304-60	71993-304	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate, Aspirin and Caffeine	Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20220318	N/A	ANDA	ANDA075141	Atland Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	385 mg/1; 30 mg/1; 25 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60)
71993-307-60	71993-307	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate, Aspirin and Caffeine	Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20230301	N/A	ANDA	ANDA075141	Atland Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770 mg/1; 60 mg/1; 50 mg/1	60 TABLET in 1 BOTTLE, PLASTIC (71993-307-60)